
Boston Scientific Corporation BSX
$ 93.46
-0.68%
Quarterly report 2025-Q3
added 11-03-2025
Boston Scientific Corporation Interest Expense 2011-2026 | BSX
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Boston Scientific Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 305 M | 265 M | 470 M | 341 M | 361 M | 473 M | 241 M | 229 M | 233 M | 284 M | 216 M | 324 M | 261 M | 281 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 473 M | 216 M | 306 M |
Quarterly Interest Expense Boston Scientific Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 87 M | 90 M | 82 M | 79 M | 77 M | 69 M | 66 M | 70 M | 65 M | - | 63 M | 64 M | 279 M | - | 86 M | 86 M | 82 M | - | 86 M | 91 M | 88 M | - | 95 M | 89 M | 109 M | - | 58 M | 57 M | 61 M | - | 57 M | 58 M | 57 M | - | 58 M | 59 M | 59 M | - | 58 M | 106 M | 60 M | - | 54 M | 53 M | 54 M | - | 137 M | 65 M | 65 M | - | 65 M | 64 M | 69 M | - | 62 M | 73 M | 75 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 279 M | 53 M | 77.5 M |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
AxoGen
AXGN
|
-199 K | $ 30.83 | -0.32 % | $ 1.36 B | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Abiomed
ABMD
|
58.7 M | - | - | $ 17.2 B | ||
|
Cognyte Software Ltd.
CGNT
|
-1.61 M | $ 9.3 | -3.23 % | $ 668 M | ||
|
CONMED Corporation
CNMD
|
37.3 M | $ 41.91 | 4.76 % | $ 1.29 B | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Apyx Medical Corporation
APYX
|
2.48 M | $ 3.87 | -0.26 % | $ 134 M | ||
|
Alphatec Holdings
ATEC
|
24.9 M | $ 15.99 | -2.8 % | $ 2.29 B | ||
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
Bio-Rad Laboratories
BIO
|
48.9 M | $ 317.35 | -1.51 % | $ 8.95 B | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 4.0 | -2.2 % | $ 149 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 49.4 | -2.91 % | $ 7.36 K | ||
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Abbott Laboratories
ABT
|
376 M | $ 124.69 | 0.35 % | $ 217 B | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
3.94 M | $ 12.46 | 0.97 % | $ 960 M | ||
|
Zynex
ZYXI
|
-440 K | - | - | $ 21.1 M | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
Electromed
ELMD
|
78 K | $ 28.27 | 1.0 % | $ 239 M | ||
|
Pulmonx Corporation
LUNG
|
256 K | $ 2.0 | 2.56 % | $ 78.2 M | ||
|
Second Sight Medical Products
EYES
|
1.19 M | - | -0.97 % | $ 54.4 M | ||
|
Align Technology
ALGN
|
7.68 M | $ 169.61 | -0.35 % | $ 12.7 B | ||
|
Accuray Incorporated
ARAY
|
13 M | $ 0.84 | -2.44 % | $ 86.3 M | ||
|
IRadimed Corporation
IRMD
|
164 K | $ 101.77 | 2.54 % | $ 1.29 B | ||
|
OrthoPediatrics Corp.
KIDS
|
-1.07 M | $ 18.52 | -0.94 % | $ 427 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
-40 K | $ 15.46 | 6.81 % | $ 418 M | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.61 | 0.08 % | $ 122 M | ||
|
Myomo
MYO
|
21.1 K | $ 0.92 | -2.58 % | $ 6.49 M | ||
|
Orthofix Medical
OFIX
|
-9.62 M | $ 14.38 | -2.94 % | $ 548 M |